How does a respiratory virus damage deep subcortical dopamine pathways? Pathological evaluations confirm that the virus rarely needs to infect neurons directly to cause widespread functional devastation. Instead, systemic immune dysregulation leaves behind chronic neuroinflammation that crosses the blood-brain barrier.
During an acute infection, inflammatory cytokines such as IL-6, TNF-alpha, and interferon-gamma surge through the bloodstream. In a subgroup of patients, this cytokine flood fails to shut down, disrupting endothelial cell junctions in cerebral blood vessels. Activated microglial cells, the resident immune defenders of the brain, shift into a persistent, neurotoxic phenotype. These hyperactive microglia cluster tightly around dopamine-rich regions because the basal ganglia possess unusually high metabolic demands and dense vascular networks.
This localized inflammatory environment produces persistent oxidative stress, directly suppressing the synthesis of tyrosine hydroxylase, the rate-limiting enzyme required to create dopamine. Simultaneously, inflammatory cytokines accelerate dopamine breakdown while downregulating transporter proteins. The resulting state leaves the central nervous system trapped in a prolonged biochemical deficit, unable to restore normal receptor balances while background inflammation persists.